|  Help  |  About  |  Contact Us

Publication : LncRNA EPR regulates intestinal mucus production and protects against inflammation and tumorigenesis.

First Author  Briata P Year  2023
Journal  Nucleic Acids Res Volume  51
Issue  10 Pages  5193-5209
PubMed ID  37070602 Mgi Jnum  J:336407
Mgi Id  MGI:7489141 Doi  10.1093/nar/gkad257
Citation  Briata P, et al. (2023) LncRNA EPR regulates intestinal mucus production and protects against inflammation and tumorigenesis. Nucleic Acids Res 51(10):5193-5209
abstractText  The long non-coding RNA EPR is expressed in epithelial tissues, binds to chromatin and controls distinct biological activities in mouse mammary gland cells. Because of its high expression in the intestine, in this study we have generated a colon-specific conditional targeted deletion (EPR cKO) to evaluate EPR in vivo functions in mice. EPR cKO mice display epithelium hyperproliferation, impaired mucus production and secretion, as well as inflammatory infiltration in the proximal portion of the large intestine. RNA sequencing analysis reveals a rearrangement of the colon crypt transcriptome with strong reduction of goblet cell-specific factors including those involved in the synthesis, assembly, transport and control of mucus proteins. Further, colon mucosa integrity and permeability are impaired in EPR cKO mice, and this results in higher susceptibility to dextran sodium sulfate (DSS)-induced colitis and tumor formation. Human EPR is down-regulated in human cancer cell lines as well as in human cancers, and overexpression of EPR in a colon cancer cell line results in enhanced expression of pro-apoptotic genes. Mechanistically, we show that EPR directly interacts with select genes involved in mucus metabolism whose expression is reduced in EPR cKO mice and that EPR deletion causes tridimensional chromatin organization changes.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

7 Bio Entities

Trail: Publication

0 Expression